Is NVS A Good Stock To Buy Right Now?

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Flexi-Pricing Scheme Unveiled For Novartis AG (ADR) (NVS) Kisqali In The Face Of Stiff Competition

After recently getting the approval of the U.S. Food and Drug Administration, Novartis AG (ADR) (NYSE:NVS) has announced that a flexible pricing system...

Keep Reading →

March 16 - News, Stock Analysis - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Positive Results For AbbVie Inc (ABBV) Humira Biosimilar Reported By Novartis AG (ADR) (NVS)

A Phase III study has shown that GP2017, which is manufactured by Sandoz, a unit of Novartis AG (ADR) (NYSE:NVS), has shown positive results as a Humira...

Keep Reading →

March 8 - News, Stock Analysis - Comments

Novartis AG (ADR) (NVS) Fined And Some Products To Be Temporarily Suspended In South Korea

Novartis AG (ADR) (NYSE:NVS) has been fined approximately $174,000 in South Korea after the company was found guilty of bribing physicians in order to...

Keep Reading →

March 3 - News, Stock Analysis - Comments

Novartis AG (ADR) (NVS) Greater Use Of Technology In Transforming Medical Education

Novartis AG (ADR) (NYSE:NVS) is quickly entering into an engagement with the use of digital technology. The idea is to enhance and increase interaction...

Keep Reading →

February 14 - News, Stock Analysis - Comments

merger, businessman, greeting, handshake, hands, business, concept, handclasp, success, friendship, symbol, partnership, tone, cooperation, people, agree, welcome,

Novartis AG (ADR) (NVS) Agrees To $50 Million Deal With Conatus Pharmaceuticals Inc (CNAT)

Novartis AG (ADR) (NYSE:NVS) and Conatus Pharmaceuticals Inc (NASDAQ:CNAT) will jointly develop Conatus drug emricasan. This has resulted from the duo...

Keep Reading →

December 20 - News, Stock Analysis - Comments

Highest Paid Medical Technicians in America

Novartis AG (ADR) (NVS) Acquires Selexys Pharmaceuticals Corp.

Novartis AG (ADR) (NYSE:NVS) has recently acquired Selexys Pharmaceuticals Corp. after receiving results from the SUSTAIN clinical trial, a Phase II clinical...

Keep Reading →

November 22 - News, Stock Analysis - Comments

Novartis AG (ADR) (NVS) And Pfizer Inc. (PFE) Are In A Race To Gain Favor In Breast Cancer

Novartis AG (ADR) (NYSE:NVS) CDK4/6 breast cancer drug remains on track with Pfizer Inc. (NYSE:PFE)‘s Ibrance. The pharma giant has already obtained...

Keep Reading →

November 2 - News - Comments

Novartis AG (NVS) Relocates NITD To California

James Bradner, Novartis AG (NYSE:NVS) Novartis Institutes for BioMedical Research President, has recently confirmed that the company will move the Novartis...

Keep Reading →

October 6 - News, Stock Analysis - Comments

Does Novartis AG (NVS) Have The Solution For Malaria?

Results for a potentially game-changing proof of concept study were just published concerning malaria by Novartis AG (NYSE:NVS) in the New England Journal...

Keep Reading →

September 22 - News, Stock Analysis - Comments

Here’s What’s Important With The Novartis AG (ADR) (NVS) MS Data

Novartis AG (ADR) (NYSE:NVS) just put out data from its multiple sclerosis (MS) trial, and it looks as if the company is winning the race to bring a drug...

Keep Reading →

August 29 - News, Stock Analysis - Comments

Novartis AG (NVS) Announces Positive Phase III Results For MS Drug

Novartis AG (NYSE:NVS) has announced that the Phase III EXPAND study, which is evaluating the efficacy and safety of oral, once daily, BAF312 in secondary...

Keep Reading →

August 26 - News, Stock Analysis - Comments

Colombia Makes Good On Its Threat Against Novartis AG (NVS)

After negotiations with Novartis AG (NYSE:NVS) to lower the price of key leukemia drug Gleevec broke off, the Colombian government is set to take matters...

Keep Reading →

June 10 - News, Stock Analysis - Comments

Posts Tagged ‘Is NVS A Good Stock To Buy Right Now?’